Epithelial-to-mesenchymal plasticity harnesses endocytic circuitries

Salvatore Corallino, Maria Grazia Malabarba, Martina Zobel, Pier Paolo Di Fiore, Giorgio Scita

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The ability of cells to alter their phenotypic and morphological characteristics, known as cellular plasticity, is critical in normal embryonic development and adult tissue repair and contributes to the pathogenesis of diseases, such as organ fibrosis and cancer. The epithelial-to-mesenchymal transition (EMT) is a type of cellular plasticity. This transition involves genetic and epigenetic changes as well as alterations in protein expression and posttranslational modifications. These changes result in reduced cell-cell adhesion, enhanced cell adhesion to the extracellular matrix, and altered organization of the cytoskeleton and of cell polarity. Among these modifications, loss of cell polarity represents the nearly invariable, distinguishing feature of EMT that frequently precedes the other traits or might even occur in their absence. EMT transforms cell morphology and physiology, and hence cell identity, from one typical of cells that form a tight barrier, like epithelial and endothelial cells, to one characterized by a highly motile mesenchymal phenotype. Time-resolved proteomic and phosphoproteomic analyses of cells undergoing EMT recently identified thousands of changes in proteins involved in many cellular processes, including cell proliferation and motility, DNA repair, and - unexpectedly - membrane trafficking (D'Souza et al., 2014). These results have highlighted a picture of great complexity. First the EMT transition is not an all-or-none response but rather a gradual process that develops over time. Second EMT events are highly dynamic and frequently reversible, involving both cell-autonomous and non-autonomous mechanisms. The net results is that EMT generates populations of mixed cells, with partial or full phenotypes, possibly accounting (at least in part) for the physiological as well as pathological cellular heterogeneity of some tissues. Endocytic circuitries have emerged as complex connectivity infrastructures for numerous cellular networks required for the execution of different biological processes, with a primary role in the control of polarized functions. Thus, they may be relevant for controlling EMT or certain aspects of it. Here, by discussing a few paradigmatic cases, we will outline how endocytosis may be harnessed by the EMT process to promote dynamic changes in cellular identity, and to increase cellular flexibility and adaptation to microenvironmental cues, ultimately impacting on physiological and pathological processes, first and foremost cancer progression.

Original languageEnglish
Article number45
JournalFrontiers in Oncology
Volume5
Issue numberFEB
DOIs
Publication statusPublished - 2015

Fingerprint

Epithelial-Mesenchymal Transition
Cell Polarity
Cell Adhesion
Physiological Phenomena
Phenotype
Biological Phenomena
Cell Physiological Phenomena
Pathologic Processes
Post Translational Protein Processing
Endocytosis
Cytoskeleton
Epigenomics
DNA Repair
Proteomics
Embryonic Development
Cell Movement
Cues
Extracellular Matrix
Neoplasms
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Epithelial-to-mesenchymal plasticity harnesses endocytic circuitries. / Corallino, Salvatore; Malabarba, Maria Grazia; Zobel, Martina; Di Fiore, Pier Paolo; Scita, Giorgio.

In: Frontiers in Oncology, Vol. 5, No. FEB, 45, 2015.

Research output: Contribution to journalArticle

Corallino, Salvatore ; Malabarba, Maria Grazia ; Zobel, Martina ; Di Fiore, Pier Paolo ; Scita, Giorgio. / Epithelial-to-mesenchymal plasticity harnesses endocytic circuitries. In: Frontiers in Oncology. 2015 ; Vol. 5, No. FEB.
@article{6fd7b0491959407d9a715a7a99424d46,
title = "Epithelial-to-mesenchymal plasticity harnesses endocytic circuitries",
abstract = "The ability of cells to alter their phenotypic and morphological characteristics, known as cellular plasticity, is critical in normal embryonic development and adult tissue repair and contributes to the pathogenesis of diseases, such as organ fibrosis and cancer. The epithelial-to-mesenchymal transition (EMT) is a type of cellular plasticity. This transition involves genetic and epigenetic changes as well as alterations in protein expression and posttranslational modifications. These changes result in reduced cell-cell adhesion, enhanced cell adhesion to the extracellular matrix, and altered organization of the cytoskeleton and of cell polarity. Among these modifications, loss of cell polarity represents the nearly invariable, distinguishing feature of EMT that frequently precedes the other traits or might even occur in their absence. EMT transforms cell morphology and physiology, and hence cell identity, from one typical of cells that form a tight barrier, like epithelial and endothelial cells, to one characterized by a highly motile mesenchymal phenotype. Time-resolved proteomic and phosphoproteomic analyses of cells undergoing EMT recently identified thousands of changes in proteins involved in many cellular processes, including cell proliferation and motility, DNA repair, and - unexpectedly - membrane trafficking (D'Souza et al., 2014). These results have highlighted a picture of great complexity. First the EMT transition is not an all-or-none response but rather a gradual process that develops over time. Second EMT events are highly dynamic and frequently reversible, involving both cell-autonomous and non-autonomous mechanisms. The net results is that EMT generates populations of mixed cells, with partial or full phenotypes, possibly accounting (at least in part) for the physiological as well as pathological cellular heterogeneity of some tissues. Endocytic circuitries have emerged as complex connectivity infrastructures for numerous cellular networks required for the execution of different biological processes, with a primary role in the control of polarized functions. Thus, they may be relevant for controlling EMT or certain aspects of it. Here, by discussing a few paradigmatic cases, we will outline how endocytosis may be harnessed by the EMT process to promote dynamic changes in cellular identity, and to increase cellular flexibility and adaptation to microenvironmental cues, ultimately impacting on physiological and pathological processes, first and foremost cancer progression.",
author = "Salvatore Corallino and Malabarba, {Maria Grazia} and Martina Zobel and {Di Fiore}, {Pier Paolo} and Giorgio Scita",
year = "2015",
doi = "10.3389/fonc.2015.00045",
language = "English",
volume = "5",
journal = "Frontiers in Oncology",
issn = "2234-943X",
publisher = "Frontiers Media S. A.",
number = "FEB",

}

TY - JOUR

T1 - Epithelial-to-mesenchymal plasticity harnesses endocytic circuitries

AU - Corallino, Salvatore

AU - Malabarba, Maria Grazia

AU - Zobel, Martina

AU - Di Fiore, Pier Paolo

AU - Scita, Giorgio

PY - 2015

Y1 - 2015

N2 - The ability of cells to alter their phenotypic and morphological characteristics, known as cellular plasticity, is critical in normal embryonic development and adult tissue repair and contributes to the pathogenesis of diseases, such as organ fibrosis and cancer. The epithelial-to-mesenchymal transition (EMT) is a type of cellular plasticity. This transition involves genetic and epigenetic changes as well as alterations in protein expression and posttranslational modifications. These changes result in reduced cell-cell adhesion, enhanced cell adhesion to the extracellular matrix, and altered organization of the cytoskeleton and of cell polarity. Among these modifications, loss of cell polarity represents the nearly invariable, distinguishing feature of EMT that frequently precedes the other traits or might even occur in their absence. EMT transforms cell morphology and physiology, and hence cell identity, from one typical of cells that form a tight barrier, like epithelial and endothelial cells, to one characterized by a highly motile mesenchymal phenotype. Time-resolved proteomic and phosphoproteomic analyses of cells undergoing EMT recently identified thousands of changes in proteins involved in many cellular processes, including cell proliferation and motility, DNA repair, and - unexpectedly - membrane trafficking (D'Souza et al., 2014). These results have highlighted a picture of great complexity. First the EMT transition is not an all-or-none response but rather a gradual process that develops over time. Second EMT events are highly dynamic and frequently reversible, involving both cell-autonomous and non-autonomous mechanisms. The net results is that EMT generates populations of mixed cells, with partial or full phenotypes, possibly accounting (at least in part) for the physiological as well as pathological cellular heterogeneity of some tissues. Endocytic circuitries have emerged as complex connectivity infrastructures for numerous cellular networks required for the execution of different biological processes, with a primary role in the control of polarized functions. Thus, they may be relevant for controlling EMT or certain aspects of it. Here, by discussing a few paradigmatic cases, we will outline how endocytosis may be harnessed by the EMT process to promote dynamic changes in cellular identity, and to increase cellular flexibility and adaptation to microenvironmental cues, ultimately impacting on physiological and pathological processes, first and foremost cancer progression.

AB - The ability of cells to alter their phenotypic and morphological characteristics, known as cellular plasticity, is critical in normal embryonic development and adult tissue repair and contributes to the pathogenesis of diseases, such as organ fibrosis and cancer. The epithelial-to-mesenchymal transition (EMT) is a type of cellular plasticity. This transition involves genetic and epigenetic changes as well as alterations in protein expression and posttranslational modifications. These changes result in reduced cell-cell adhesion, enhanced cell adhesion to the extracellular matrix, and altered organization of the cytoskeleton and of cell polarity. Among these modifications, loss of cell polarity represents the nearly invariable, distinguishing feature of EMT that frequently precedes the other traits or might even occur in their absence. EMT transforms cell morphology and physiology, and hence cell identity, from one typical of cells that form a tight barrier, like epithelial and endothelial cells, to one characterized by a highly motile mesenchymal phenotype. Time-resolved proteomic and phosphoproteomic analyses of cells undergoing EMT recently identified thousands of changes in proteins involved in many cellular processes, including cell proliferation and motility, DNA repair, and - unexpectedly - membrane trafficking (D'Souza et al., 2014). These results have highlighted a picture of great complexity. First the EMT transition is not an all-or-none response but rather a gradual process that develops over time. Second EMT events are highly dynamic and frequently reversible, involving both cell-autonomous and non-autonomous mechanisms. The net results is that EMT generates populations of mixed cells, with partial or full phenotypes, possibly accounting (at least in part) for the physiological as well as pathological cellular heterogeneity of some tissues. Endocytic circuitries have emerged as complex connectivity infrastructures for numerous cellular networks required for the execution of different biological processes, with a primary role in the control of polarized functions. Thus, they may be relevant for controlling EMT or certain aspects of it. Here, by discussing a few paradigmatic cases, we will outline how endocytosis may be harnessed by the EMT process to promote dynamic changes in cellular identity, and to increase cellular flexibility and adaptation to microenvironmental cues, ultimately impacting on physiological and pathological processes, first and foremost cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84923557432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923557432&partnerID=8YFLogxK

U2 - 10.3389/fonc.2015.00045

DO - 10.3389/fonc.2015.00045

M3 - Article

AN - SCOPUS:84923557432

VL - 5

JO - Frontiers in Oncology

JF - Frontiers in Oncology

SN - 2234-943X

IS - FEB

M1 - 45

ER -